Klaudia Steplewski

6.0k citations

18 papers · 1.6k indexed · h-index 15

Co-authors: Vidadi Yusibov Hilary Koprowski D. Craig Hooper A. Modelska Do‐Youn Oh Jeffrey R. Infante Bradley G. Somer Nabil A. Elshourbagy
Topics: Peroxisome Proliferator-Activated Receptors (4 papers)Pancreatic and Hepatic Oncology Research (3 papers)Plant Virus Research Studies (3 papers)
Cited by: Biotechnology Oncology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States United Kingdom Germany

In The Last Decade

Klaudia Steplewski

18 papers receiving 1.5k citations

Peers

Countries citing papers authored by Klaudia Steplewski

Since Specialization

Citations

This map shows the geographic impact of Klaudia Steplewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaudia Steplewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaudia Steplewski more than expected).

Fields of papers citing papers by Klaudia Steplewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaudia Steplewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaudia Steplewski. The network helps show where Klaudia Steplewski may publish in the future.

Co-authorship network of co-authors of Klaudia Steplewski

This figure shows the co-authorship network connecting the top 25 collaborators of Klaudia Steplewski. A scholar is included among the top collaborators of Klaudia Steplewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaudia Steplewski. Klaudia Steplewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy 2024 ·Drug Safety ·E. Cohen,Arie Regev,Anju Garg,Adrian M. Di Bisceglie,James H. Lewis,John M. Vierling,Judith Hey‐Hadavi,Klaudia Steplewski,(unknown),(unknown),Nonko Pehlivanov,Stuart Kendrick,Mark Avigan	6
2	A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas 2014 ·European Journal of Cancer ·Jeffrey R. Infante,Bradley G. Somer,Joon Oh Park,Chung‐Pin Li,M. E. Scheulen,(unknown),Do‐Youn Oh,Yuan Liu,Suman Redhu,Klaudia Steplewski,Ngocdiep T. Le	271
3	A randomized, double-blind, placebo-controlled trial of trametinib, a MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas. 2013 ·Journal of Clinical Oncology ·Jeffrey R. Infante,Bradley G. Somer,Joon Oh Park,Chung‐Pin Li,M. E. Scheulen,(unknown),Do‐Youn Oh,Yuan Liu,Soumi Lahiri,Klaudia Steplewski,Ngocdiep T. Le	13
4	Circulating cytokines and angiogenic factors (CAF) as markers of clinical response in the study of trametinib (T) plus gemcitabine (G) versus placebo (P) plus gemcitabine for patients (pts) with untreated metastatic adenocarcinoma of the pancreas (MEK113487). 2013 ·Journal of Clinical Oncology ·John V. Heymach,Hai T. Tran,Andrew B. Nixon,Herbert I. Hurwitz,Jeffrey R. Infante,Robert Gagnon,Klaudia Steplewski,Ngocdiep T. Le,Yuan Liu	3
5	Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression‐free survival in patients with HER2‐positive metastatic breast cancer receiving lapatinib monotherapy 2011 ·Cancer ·Allan Lipton,Kim Leitzel,Suhail M. Ali,Walter P. Carney,(unknown),Klaudia Steplewski,Ron E. Westlund,Robert Gagnon,Anne‐Marie Martin,J. Maltzman	19
6	Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases 2011 ·Journal of Neuro-Oncology ·Nancy U. Lin,(unknown),Richard Greil,Mario Campone,Bella Kaufman,Klaudia Steplewski,Stephen Lane,Denise Zembryki,Stephen D. Rubin,Eric P. Winer	126
7	In Vivo Activation of Peroxisome Proliferator-Activated Receptor-δ Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Tianli Yue,Sandhya S. Nerurkar,Weike Bao,Beat M. Jucker,Lea Sarov‐Blat,Klaudia Steplewski,Eliot H. Ohlstein,Robert N. Willette	59
8	Site-Specific Atherogenic Gene Expression Correlates With Subsequent Variable Lesion Development in Coronary and Peripheral Vasculature 2008 ·Arteriosclerosis Thrombosis and Vascular Biology ·Emile R. Mohler,Lea Sarov‐Blat,Yi Shi,Damir Hamamdzic,Andrew Zalewski,Colin H. Macphee,(unknown),(unknown),Sumeet K. Mainigi,Hashim Osman,(unknown),Klaudia Steplewski,Zachary M. Gertz,Min Lü,Robert L. Wilensky	51
9	PPARδ Activation Normalizes Cardiac Substrate Metabolism and Reduces Right Ventricular Hypertrophy in Congestive Heart Failure 2007 ·Journal of Cardiovascular Pharmacology ·Beat M. Jucker,Christopher Doe,Christine G. Schnackenberg,Alan R. Olzinski,Kristeen Maniscalco,Carolyn Williams,Tom C. Hu,Stephen C. Lenhard,Melissa H. Costell,(unknown),Lea Sarov‐Blat,Klaudia Steplewski,Robert N. Willette	31
10	Predominance of a Proinflammatory Phenotype in Monocyte-Derived Macrophages From Subjects With Low Plasma HDL-Cholesterol 2007 ·Arteriosclerosis Thrombosis and Vascular Biology ·Lea Sarov‐Blat,Róbert Kiss,Bassam Haidar,Nihan Kavaslar,Michael Jaye,(unknown),Klaudia Steplewski,Mark R. Hurle,Dennis L. Sprecher,Ruth McPherson,Yves L. Marcel	30
11	Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation 2007 ·Biochemical and Biophysical Research Communications ·Frank Lezoualc’h,Klaudia Steplewski,Laura Sartiani,Alessandro Mugelli,Rodolphe Fischmeister,Antoine Bril	29
12	Functional characterization of an orphan nuclear receptor, Rev‐ErbAα, in chondrocytes and its potential role in osteoarthritis 2006 ·Arthritis & Rheumatism ·Pankaj Chaturvedi,Michael A. Pratta,Klaudia Steplewski,J.T.H. Connor,(unknown)	14
13	Neuromedin Elicits Cytokine Release in Murine Th2-Type T Cell Clone D10.G4.1 2004 ·The Journal of Immunology ·Eric N. Johnson,Edward R. Appelbaum,(unknown),Richard F. Cox,Jyoti Disa,James J. Foley,Sujoy Ghosh,Diane P. Naselsky,Mark Pullen,Henry M. Sarau,(unknown),Klaudia Steplewski,Meirav Zaks‐Zilberman,Nambi Aiyar	43
14	Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators 2004 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Douglas G. Johns,Zhaohui Ao,Diane P. Naselsky,Christopher L. Herold,Kristeen Maniscalco,Lea Sarov‐Blat,Klaudia Steplewski,Nambi Aiyar,Stephen A. Douglas	92
15	Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid 2003 ·Journal of Biological Chemistry ·Alan Wise,Steven M. Foord,Neil J. Fraser,Ashley Barnes,Nabil A. Elshourbagy,(unknown),Diane M. Ignar,Paul R. Murdock,Klaudia Steplewski,Andrew R. Green,Andrew J. Brown,Simon J. Dowell,Philip Szekeres,David G. Hassall,Fiona H. Marshall,Shelagh Wilson,Nicholas B. Pike	440
16	Expression of alfalfa mosaic virus coat protein in tobacco mosaic virus (TMV) deficient in the production of its native coat protein supports long-distance movement of a chimeric TMV 1999 ·Proceedings of the National Academy of Sciences ·Sergei Spitsin,Klaudia Steplewski,(unknown),Hélène Bélanger,Tatiana Mikheeva,(unknown),William O. Dawson,Hilary Koprowski,Vidadi Yusibov	36
17	Immunization against rabies with plant-derived antigen 1998 ·Proceedings of the National Academy of Sciences ·A. Modelska,B Dietzschold,(unknown),Zhen F. Fu,Klaudia Steplewski,D. Craig Hooper,Hilary Koprowski,Vidadi Yusibov	156
18	Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1 1997 ·Proceedings of the National Academy of Sciences ·Vidadi Yusibov,A. Modelska,Klaudia Steplewski,(unknown),David B. Weiner,D. Craig Hooper,Hilary Koprowski	174

About Klaudia Steplewski

Klaudia Steplewski is a scholar working on Biotechnology, Hepatology and Cancer Research, having authored 18 papers that have together received 1.6k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Plant Virus Research Studies (3 papers). The work is most often cited by research in Biotechnology (300 citations), Oncology (408 citations) and Cancer Research (190 citations). Klaudia Steplewski has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Vidadi Yusibov, Hilary Koprowski, D. Craig Hooper, A. Modelska, Do‐Youn Oh, Jeffrey R. Infante, Bradley G. Somer, Nabil A. Elshourbagy, Steven M. Foord and Alan Wise. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact